📋 Tender Overview
Contract awarded for Cardiovascular medications 2025 lot-0016, title: digoxin - inj. sol. 0.25 mg/ml, vial 2 ml, description: med. cardiovascular lot-0017, title: digoxin - tab. 0.25 mg, description: med cardiovascular lot-0020, title: isosorbide mononitrate - caps. release pre 40 mg, description: med cardiovascular lot-0026, title: ondansetron - inj. sol. 2 mg/ml, fi. 4 ml, description: med cardiovascular lot-0032, title: metoprolol - inj./perf. 5 mg/5 ml, vial 5 ml, description: med cardiovascular lot-0036, title: enalapril - inj. sol. 1.25 mg/ml, vial 1 ml, description: med cardiovascular lot-0046, title: zofenopril - film-coated tab. 7.5 mg, description: med cardiovascular lot-0047, title: zofenopril - film-coated tab. 30 mg, description: med cardiovascular lot-0069, title: phenobarbital - inj. sol. 10%, vial 2 ml, description: med cardiovascular lot-0070, title: phenobarbital - tab. 100 mg, description: med cardiovascular lot-0116, title: oxytetracycline + hydrocortisone - spray; oxytetracycline + hydrocortisone (0.255 g + 0.085 g), description: med cardiovascular lot-0118, title: lorazepam - tab. 1 mg, description: med cardiovascular lot-0121, title: atracurium - inj. sol. 10 mg/ml, vial 5 ml, description: med cardiovascular lot-0129, title: ketamine - inj. sol. 50 mg/5 ml, fi 5 ml, description: med cardiovascular lot-0169, title: tropicamide + phenylephrine + lidocaine - inj. sol. 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml; fi. 0.6 ml, description: med cardiovascular lot-0175, title: dabigatran etexilate - caps. 110 mg, description: med cardiovascular lot-0179, title: cabazitaxel innovative - flc. 60 mg/1.5 ml, description: med cardiovascular estimated value excluding vat: 145495.80 ron.Cardiovascular medications 2025